Eye health hero to be honoured at IAPB

Article

Dr Albrecht Hennig, inventor of the 'Fish Hook Technique' for cataract surgery, will be one of the 'Eye Health Heroes' honoured at the International Agency for the Prevention of Blindness (IAPB) 2012 9th General Assembly.

Dr Albrecht Hennig, inventor of the 'Fish Hook Technique' for cataract surgery, will be one of the 'Eye Health Heroes' honoured at the International Agency for the Prevention of Blindness (IAPB) 2012 9th General Assembly.

The event, to be held in Hyderbad, India from 17–20 September, will play host to a plethora of eyecare professionals including Dr Hennig who runs the Sagarmantha Choudhary Eye Hospital (SCEH), Lahan, Nepal.

Dr Hennig has heavily contributed towards reducing blindness in Nepal with a 79% decrease in the Sagarmatha Zone and a 65% decrease in the Koshi Zone. The SCEH was primarily a 12-bed hospital, but today it has blossomed into a network of two high-volume hospitals and eight eye care centres.

Dr Hennig has completed over 115,000 cataract surgeries on both adults and children. He said, "Seeing this positive change in children and knowing that with their improved vision they will have better chances in life is my biggest reward."

In addition to this, there will be a large scientific program featuring 40 courses, keynote lectures and symposia, as well as a trade exhibition.

To register your place at the IAPB and take advantage of a special discount please visit www.9ga.iapb.org

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.